Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation

Author(s): Rosalinda Madonna, Felix B. Engel, Sean M. Davidson, Peter Ferdinandy, Aniko Gorbe, Joost P.G. Sluijter, Linda W. Van Laake.

Journal Name: Current Drug Targets

Volume 16 , Issue 8 , 2015

  Journal Home
Translate in Chinese
Submit Manuscript
Submit Proposal

Abstract:

Aging affects endogenous stem cells in terms of functionality and numbers. In particular, during aging, the stemness property can decrease because of enhanced apoptotic cell death and senescence. In addition, aging and agingrelated co-morbidities affect the paracrine activity of stem cells and the efficiency of their transplantation. Collectively, this leads to a reduction of the capacity of organs to repair themselves, possibly due to a reduced functional capability of stem cells. Therefore, major efforts have been invested to improve the repair capability of stem cells in aged individuals by overexpressing antisenescence and antiapoptotic genes. In this review, we describe critical genes and signaling pathways in stem cell aging and discuss ex vivo genetic modification approaches aimed at stem cell rejuvenation that are of interest for the cardiovascular system.

Keywords: Aging, diabetes, gene therapy, hippo, hyperlipidemia, myocardin, Notch, Pim-1, YAP, stem cell, rejuvenation, telomerase.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 16
ISSUE: 8
Year: 2015
Page: [780 - 785]
Pages: 6
DOI: 10.2174/1389450116666141205153258
Price: $58

Article Metrics

PDF: 34